PublizoomAward notice Supplies
Raamovereenkomst voor het leveren van Cytostatica Parenteraal
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- Hospilim VZW
Diepenbeek - Place of performance
- 3590 Diepenbeek, Limburg
not published: buyer's address - Estimated value
- €375,000,000 excl. VAT
- Amount awarded
- €375,000,000 excl. VAT
- Planned end of contract
- 12 December 2027
likely re-tender around June 2027 - Bids received
- 4
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 26 January 2024
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Raamovereenkomst voor het leveren van Cytostatica Parenteraal Ref.: 2023-HospiLim-104
Awarded to
58 lots
- Atezolizumab infusie 840 mg / 14 ml
- Atezolizumab infusie 1.200 mg / 20 ml
- Avelumab
- Azacitidine injectie 100 mg
- Azacitidine injectie 150 mg
- Bendamustine
- Bendamustine infusie 100 mg / 4 ml
- Bevacizumab
- Bortezomib
- Cabazitaxel
- Cabazitaxel infusie 60 mg / 3 ml
- Carboplatine
- Cisplatine
- Cladribine infusie 10 mg / 10 ml
- Cladribine injectie 10 mg / 5 ml
- Cyclofosfamide
- Cytarabine
- Cytarabine injectie/infusie 100 mg / 5 ml
- Dacarbazine
- Daratumumab
- Daunorubicine
- Daunorubicine + Cytarabine
- Docetaxel
- Doxorubicine infusie
- Doxorubicine infusie 50 mg
- Doxorubicine infusie/instillatie
- Durvalumab
- Epirubicine
- Etoposide
- Fludarabine
- Fluorouracil
- Gemcitabine
- Ifosfamide
- Irinotecan gepegyleerd liposomaal infusie
- Irinotecan infusie
- Methotrexaat injectie
- Methotrexaat injectie/infusie
- Methotrexaat injectie/infusie 5 g / 50 ml
- Methotrexaat injectie/infusie 500 mg / 20 ml
- Mitomycine
- Nivolumab
- Oxaliplatine
- Paclitaxel infusie 100 mg
- Paclitaxel
- Pembrolizumab
- Pemetrexed
- Rituximab
- Rituximab injectie 1 400 mg / 11,7 ml
- Rituximab injectie 1 600 mg / 13,4 ml
- Temozolomide
- Thiotepa
- Topotecan
- Trastuzumab emtansine infusie
- Trastuzumab infusie
- Trastuzumab injectie
- Vinblastine
- Vincrisitine
- Vinorelbine
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst voor de levering van contrastmiddelen Hospilim VZW · 5 May 2026 |
Bayer GE HEALTHCARE Bracco Imaging Europe GUERBET |
€22,614,392 |
| Totale Parenterale Nutritie (TPN) Mini Competitie JESSA-NH-STZH-SFZ Hospilim VZW · 30 September 2024 |
Baxter Belgium srl Fresenius Kabi NV |
– |
| Totale Parentale Nutritie (TPN) Mini competitie ZOL-AZV Hospilim VZW · 6 June 2024 |
Fresenius Kabi NV | – |
| Raamovereenkomst voor het leveren van Cytostatica Oraal Hospilim VZW · 29 January 2024 |
Accord Healthcare BV Arega Pharma BV Baxter Belgium srl Astellas Pharma B.V. Novartis Pharma nv Sandoz nv |
€11,000,000 |
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 55457-2024.